Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fibroblast growth factor 21 mutations

Fibroblast growth factor 21 mutations

US Patent 9023791 · Granted May 5, 2015

Estimated economic value: $19,810,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Multispecific antibody molecules comprising lambda and kappa light chains2025
Antibody molecules that bind to NKP30 and uses thereof2025
Multifunctional molecules that bind to T cell related cancer cells and uses ther2025
Anti-TCR antibody molecules and uses thereof2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Anti-TCR antibody molecules and uses thereof2025
Calreticulin binding constructs and engineered T cells for the treatment of dise2025
Anti-CCR7 antibody drug conjugates2024
Antibody drug conjugates for ablating hematopoietic stem cells2024
Multifunctional molecules that bind to calreticulin and uses thereof2024
Multispecific molecules and uses thereof2024